A Solid State Tissue Equivalent Detector for Microdosimetry, Phase I

QEL proposes to construct a tissue equivalent microdosimeter using a solid state tissue equivalent detector (SSTED). The Phase I study will produce the working SSTEDs and the Phase II will provide a viable completed microdosimeter. An organic semiconductor device based on QEL's novel design is described. The expected electrical properties of the device both in the quiescent state and under exposure are calculated. The fabrication process is described in detail and the supporting electronics are defined as well. A complete set of tests that will determine the feasibilty of the SSTEDs is defined. The first test will determine if the detectors' response matches the expected response based on detector geometry. The subsequent tests will determine the sensitivity, calibration factors, and tissues equivalence of the fabricated devices.

This is a mature technology (TRL 7+) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.